Arcus Biosciences, Inc. (RCUS)
29.21
-1.38
(-4.51%)
USD |
NYSE |
Aug 28, 16:00
29.18
-0.03
(-0.10%)
After-Hours: 20:00
Arcus Biosciences 30-Day Average Daily Volume : 1.159M for Aug. 28, 2026
30-Day Average Daily Volume Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 30-Day Average Daily Volume Data
| Date | Value |
|---|---|
| August 28, 2026 | 1.159M |
| August 27, 2026 | 1.149M |
| August 26, 2026 | 1.165M |
| August 25, 2026 | 1.166M |
| August 24, 2026 | 1.171M |
| August 21, 2026 | 1.160M |
| August 20, 2026 | 1.152M |
| August 19, 2026 | 1.125M |
| August 18, 2026 | 1.103M |
| August 17, 2026 | 1.099M |
| August 14, 2026 | 1.052M |
| August 13, 2026 | 1.058M |
| August 12, 2026 | 1.081M |
| August 11, 2026 | 1.094M |
| August 10, 2026 | 1.121M |
| August 07, 2026 | 1.235M |
| August 06, 2026 | 1.284M |
| August 05, 2026 | 1.253M |
| August 04, 2026 | 1.297M |
| August 03, 2026 | 1.388M |
| July 31, 2026 | 1.436M |
| July 30, 2026 | 1.425M |
| July 29, 2026 | 1.421M |
| July 28, 2026 | 1.433M |
| July 27, 2026 | 1.428M |
| Date | Value |
|---|---|
| July 24, 2026 | 1.429M |
| July 23, 2026 | 1.463M |
| July 22, 2026 | 1.461M |
| July 21, 2026 | 1.453M |
| July 20, 2026 | 1.452M |
| July 17, 2026 | 1.435M |
| July 16, 2026 | 1.441M |
| July 15, 2026 | 1.437M |
| July 14, 2026 | 1.461M |
| July 13, 2026 | 1.507M |
| July 10, 2026 | 1.499M |
| July 09, 2026 | 1.498M |
| July 08, 2026 | 1.509M |
| July 07, 2026 | 1.489M |
| July 06, 2026 | 1.476M |
| July 02, 2026 | 1.477M |
| July 01, 2026 | 1.458M |
| June 30, 2026 | 1.440M |
| June 29, 2026 | 1.427M |
| June 26, 2026 | 1.398M |
| June 25, 2026 | 1.275M |
| June 24, 2026 | 1.214M |
| June 23, 2026 | 1.176M |
| June 22, 2026 | 1.130M |
| June 18, 2026 | 1.040M |
30-Day Average Daily Volume Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
30-Day Average Daily Volume Benchmarks
| Halozyme Therapeutics, Inc. | 2.152M |
| AVITA Medical, Inc. | 577202.5 |
| Iovance Biotherapeutics, Inc. | 17.79M |
| Editas Medicine, Inc. | 2.172M |
| Recursion Pharmaceuticals, Inc. | 16.15M |